146 related articles for article (PubMed ID: 31030032)
1. Risk factors for symptomatic venous thromboembolism during therapy for childhood acute lymphoblastic leukemia.
Mateos MK; Trahair TN; Mayoh C; Barbaro PM; Sutton R; Revesz T; Barbaric D; Giles JE; Alvaro F; Mechinaud F; Catchpoole D; Kotecha RS; Dalla-Pozza L; Quinn MCJ; MacGregor S; Chenevix-Trench G; Marshall GM
Thromb Res; 2019 Jun; 178():132-138. PubMed ID: 31030032
[TBL] [Abstract][Full Text] [Related]
2. Obesity and risk for venous thromboembolism from contemporary therapy for pediatric acute lymphoblastic leukemia.
Prasca S; Carmona R; Ji L; Ko RH; Bhojwani D; Rawlins YA; Mittelman SD; Young G; Orgel E
Thromb Res; 2018 May; 165():44-50. PubMed ID: 29567586
[TBL] [Abstract][Full Text] [Related]
3. Venous thromboembolism following L-asparaginase treatment for lymphoid malignancies in Korea.
Lee JH; Lee J; Yhim HY; Oh D; Bang SM
J Thromb Haemost; 2017 Apr; 15(4):655-661. PubMed ID: 28150907
[TBL] [Abstract][Full Text] [Related]
4. Incidence and Risk Factors of Venous Thromboembolism in Childhood Acute Lymphoblastic Leukaemia - a Population-Based Analysis of the Austrian Berlin-Frankfurt-Münster (BFM) Study Group.
Gidl A; Füreder A; Benesch M; Dworzak M; Engstler G; Jones N; Kropshofer G; Pötschger U; Poyer F; Tamesberger M; Witt V; Mann G; Attarbaschi A;
Pediatr Hematol Oncol; 2023 Mar; 40(2):181-191. PubMed ID: 35848787
[TBL] [Abstract][Full Text] [Related]
5. TropicALL study: Thromboprophylaxis in Children treated for Acute Lymphoblastic Leukemia with Low-molecular-weight heparin: a multicenter randomized controlled trial.
Klaassen ILM; Lauw MN; van de Wetering MD; Biemond BJ; Middeldorp S; Abbink FCH; Bierings M; Te Loo DMMW; Pieters R; van der Sluis IM; Tissing WJE; Michel Zwaan C; Heleen van Ommen C
BMC Pediatr; 2017 May; 17(1):122. PubMed ID: 28486976
[TBL] [Abstract][Full Text] [Related]
6. Venous thromboembolism incidence and risk factors in adults with acute lymphoblastic leukemia treated with and without pegylated E. coli asparaginase-containing regimens.
Kashanian SM; Holtzman NG; Patzke CL; Cornu J; Duffy A; Koka M; Niyongere S; Duong VH; Baer MR; Apata J; Kamangar F; Emadi A
Cancer Chemother Pharmacol; 2021 Jun; 87(6):817-826. PubMed ID: 33677674
[TBL] [Abstract][Full Text] [Related]
7. Screening for coagulopathy and identification of children with acute lymphoblastic leukemia at a higher risk of symptomatic venous thrombosis: an AIEOP experience.
Santoro N; Colombini A; Silvestri D; Grassi M; Giordano P; Parasole R; Barisone E; Caruso R; Conter V; Valsecchi MG; Masera G; Rizzari C
J Pediatr Hematol Oncol; 2013 Jul; 35(5):348-55. PubMed ID: 23619106
[TBL] [Abstract][Full Text] [Related]
8. A retrospective study of venous thromboembolism in acute leukemia patients treated at the University of Texas MD Anderson Cancer Center.
Vu K; Luong NV; Hubbard J; Zalpour A; Faderl S; Thomas DA; Yang D; Kantarjian H; Kroll MH
Cancer Med; 2015 Jan; 4(1):27-35. PubMed ID: 25487644
[TBL] [Abstract][Full Text] [Related]
9. L-asparaginase and venous thromboembolism in acute lymphocytic leukemia.
Goyal G; Bhatt VR
Future Oncol; 2015; 11(17):2459-70. PubMed ID: 26274336
[TBL] [Abstract][Full Text] [Related]
10. Venous thromboembolism in children with acute lymphoblastic leukemia in China: a report from the Chinese Children's Cancer Group-ALL-2015.
Yin M; Wang H; Guan X; Gao J; Yang M; Wang N; Liu T; Tang J; Leung AWK; Zhou F; Wu X; Huang J; Li H; Hu S; Tian X; Jiang H; Cai J; Zhai X; Shen S; Hu Q
Front Med; 2023 Jun; 17(3):518-526. PubMed ID: 36807106
[TBL] [Abstract][Full Text] [Related]
11. Evaluation for inherited and acquired prothrombotic defects predisposing to symptomatic thromboembolism in children with acute lymphoblastic leukemia: a protocol for a prospective, observational, cohort study.
Athale UH; Laverdiere C; Nayiager T; Delva YL; Foster G; Thabane L; Chan AK
BMC Cancer; 2017 May; 17(1):313. PubMed ID: 28472942
[TBL] [Abstract][Full Text] [Related]
12. Venous thromboembolism in pediatric patients with acute lymphoblastic leukemia under chemotherapy treatment. Risk factors and usefulness of thromboprophylaxis. Results of LAL-SEHOP-PETHEMA-2013.
Ruiz-Llobet A; Gassiot S; Sarrate E; Zubicaray J; Dapena JL; Rives S; Sevilla J; Menárguez López Á; Panesso Romero M; Montoya C; Vagace JM; Molina Hurtado JR; García-Morín M; García Abós M; Mendoza Sánchez MC; Lendínez F; Palomo Moraleda P; Tallón M; González B; Urrutia E; Serna JV; Peláez Pleguezuelos I; Martínez Merino M; Ramos Elbal E; Orellana E; Benítez Muñoz H; Berrueco R
J Thromb Haemost; 2022 Jun; 20(6):1390-1399. PubMed ID: 35289066
[TBL] [Abstract][Full Text] [Related]
13. Venous thromboembolism in adults treated for acute lymphoblastic leukaemia: Effect of fresh frozen plasma supplementation.
Lauw MN; Van der Holt B; Middeldorp S; Meijers JC; Cornelissen JJ; Biemond BJ
Thromb Haemost; 2013 Apr; 109(4):633-42. PubMed ID: 23364346
[TBL] [Abstract][Full Text] [Related]
14. The successful non-invasive management of pulmonary thromboembolism in a child with acute lymphoblastic leukemia.
Ok Bozkaya I; Cetin I; Yarali N; Bayram C; Ozisik K; Ari ME; Tunc B
Arch Argent Pediatr; 2016 Feb; 114(1):e17-20. PubMed ID: 26914084
[TBL] [Abstract][Full Text] [Related]
15. Candidate single nucleotide polymorphisms and thromboembolism in acute lymphoblastic leukemia - A NOPHO ALL2008 study.
Jarvis KB; LeBlanc M; Tulstrup M; Nielsen RL; Albertsen BK; Gupta R; Huttunen P; Jónsson ÓG; Rank CU; Ranta S; Ruud E; Saks K; Trakymiene SS; Tuckuviene R; Schmiegelow K
Thromb Res; 2019 Dec; 184():92-98. PubMed ID: 31715544
[TBL] [Abstract][Full Text] [Related]
16. Markers of hypercoagulability in children with newly diagnosed acute lymphoblastic leukemia.
Carmona R; Kizilocak H; Marquez-Casas E; Vasquez S; Ji L; Ko RH; Young G; Jaffray J
Pediatr Blood Cancer; 2022 Mar; 69(3):e29522. PubMed ID: 34963026
[TBL] [Abstract][Full Text] [Related]
17. Thrombosis in children with acute lymphoblastic leukemia treated at a tertiary care center in Lebanon: revisiting the role of predictive models.
Al-Aridi C; Abboud MR; Saab R; Eid D; Jeha S; Chan AK; Muwakkit SA
Pediatr Hematol Oncol; 2011 Nov; 28(8):676-81. PubMed ID: 21787123
[TBL] [Abstract][Full Text] [Related]
18. Increasing Incidence and Recurrence Rate of Venous Thromboembolism in Paediatric Oncology Patients in One Single Centre Over 25 Years.
Klaassen ILM; van Els AL; van de Wetering MD; van Ommen CH
Thromb Haemost; 2017 Nov; 117(11):2156-2162. PubMed ID: 28981557
[TBL] [Abstract][Full Text] [Related]
19. Patterns of Venous Thromboembolism Prophylaxis During Treatment of Acute Leukemia: Results of a North American Web-Based Survey.
Lee EJ; Smith BD; Merrey JW; Lee AI; Podoltsev NA; Barbarotta L; Litzow MR; Prebet T; Luger SM; Gore S; Streiff MB; Zeidan AM
Clin Lymphoma Myeloma Leuk; 2015 Dec; 15(12):766-770. PubMed ID: 26363982
[TBL] [Abstract][Full Text] [Related]
20. Validation of a predictive model for identifying an increased risk for thromboembolism in children with acute lymphoblastic leukemia: results of a multicenter cohort study.
Mitchell L; Lambers M; Flege S; Kenet G; Li-Thiao-Te V; Holzhauer S; Bidlingmaier C; Frühwald MC; Heller C; Schmidt W; Pautard B; Nowak-Göttl U
Blood; 2010 Jun; 115(24):4999-5004. PubMed ID: 20339086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
